BioSpace News Archive

K-One MediTech To Begin Production of CE approved 15-Minute Antigen Test Solution

Woven Science is the first company to take a holistic approach to mental wellbeing through psychedelic models of care, while putting a system of reciprocity towards indigenous communities at the core of its business.

AliveCor, a leading innovator in FDA-cleared personal electrocardiogram technology and services, announced that the US International Trade Commission issued a Notice of Institution of an Investigation into Apple’s alleged infringement of three AliveCor patents.

RYBREVANT™ is the first fully-human, bispecific antibody approved in lung cancer Simultaneous FDA approval of a companion diagnostic aids in the identification of exon 20 insertion mutations

ulrich medical USA , Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States , reported that the first quarter of 2021 marked the strongest quarterly revenue in the company’s history.

Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Opdivo (nivolumab) plus Yervoy (ipilimumab) for Treatment of Mismatch Repair Deficient or Microsatellite Instability–High Metastatic Colorectal Cancer After Prior Chemotherapy Application based on positive results from the Phase 2 CheckMate -142 trial demonstrating a durable clinical benefit in the Opdivo plus Yervoy cohort Recommendation from the CHMP represents the first positi

The U.S. Food and Drug Administration announced that U.S. Marshals, at the agency’s request, seized more than 207,000 units of dietary supplements and bulk dietary ingredients that are or contain kratom, including over 34,000 kilograms of bulk kratom.

Company Announcement Janssen received a positive CHMP opinion for DARZALEX ® SC (daratumumab and hyaluronidase-fihj) in combination with bortezomib, cyclophosphamide and dexamethasone for the treatment of adult patients with newly diagnosed systemic light-chain (AL) amyloidosis Opinion based on data from the Phase 3 ANDROMEDA (AMY3001) study CHMP also issued a positive opinion recommending DARZALEX ®

MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced that Jean-Paul Kress, M.D., the companys Chief Executive Officer, will participate in a fireside chat at the UBS Global Healthcare Conference on Tuesday May 25, 2021 at 7:00 a.m. Eastern Time.

Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for Friedreich’s ataxia (FA) and other complex rare diseases, today announced that it has executed a securities purchase agreement to raise gross proceeds of approximately $95 million in a private placement financing of common stock (or pre-funded warrants to purchase common stock in lieu thereof).